Quarterly report [Sections 13 or 15(d)]

Unaudited Interim Condensed Consolidated Statements of Stockholders??? Equity

v3.26.1
Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2024   79,419,028      
Beginning Balance at Dec. 31, 2024 $ 221,938 $ 7 $ 407,076 $ 1,753 $ (186,898)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1,568,167      
Issuance of common stock upon exercise of stock options 60   60    
Issuance of common stock upon settlement of restricted stock units (in shares)   1,465,407      
Issuance of common stock upon settlement of restricted stock units 0        
Stock-based compensation - restricted stock 4,217   4,217    
Shares withheld related to net share settlement (in shares)   (1,478,968)      
Shares withheld related to net share settlement (4,306)   (4,306)    
Other comprehensive income 1,316     1,316  
Net income (loss) (3,493)       (3,493)
Ending Balance (in shares) at Mar. 31, 2025   80,973,634      
Ending Balance at Mar. 31, 2025 219,732 $ 7 407,047 3,069 (190,391)
Beginning Balance (in shares) at Dec. 31, 2025   86,702,183      
Beginning Balance at Dec. 31, 2025 $ 279,072 $ 7 424,616 0 (145,551)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 286,960 286,960      
Issuance of common stock upon exercise of stock options $ 52   52    
Issuance of common stock upon settlement of restricted stock units (in shares)   336,098      
Issuance of common stock upon settlement of restricted stock units 0        
Stock-based compensation - restricted stock 5,035   5,035    
Shares withheld related to net share settlement (in shares)   (128,337)      
Shares withheld related to net share settlement (582)   (582)    
Retirement of common stock (in shares)   (675,334)      
Other comprehensive income 0        
Net income (loss) 2,154       2,154
Ending Balance (in shares) at Mar. 31, 2026   86,521,570      
Ending Balance at Mar. 31, 2026 $ 285,731 $ 7 $ 429,121 $ 0 $ (143,397)